Charles Schwab Investment Management »

Candel Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $324k 47k 6.93
2024-06-30 $290k 47k 6.20

More positions owned by Charles Schwab Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Broadcom (AVGO)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Schwab Strategic Tr Fundamental Intl (FNDF)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Charles Schwab Investment Management

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Sands Capital Ventures
Nuveen Asset Management
Susquehanna International
Northern Trust
Citadel Advisors
Bridgeway Capital Management
Jane Street
HB Wealth Management
Charles Schwab Investment Management

View all funds holding Candel Therapeutics